SHANGHAI, Nov 12 (Reuters) – China has approved Eli Lilly's weight loss pill orforglipron, the country's medicine regulator said on Thursday. (Reporting by Andrew Silver; additional reporting from
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Pioneering Defence Innovation with Rayonix Tech and XTEND to Deliver Next-Generation Autonomous Tactical Drones for…
Nov 12 (Reuters) - SSAB AB (publ): * SIGNS NEW REVOLVING CREDIT FACILITY OF EUR…
By Ankur Banerjee SINGAPORE, Nov 12 (Reuters) - Investors fear an ouster of CEO Jensen…
Nov 12 (Reuters) - Tecnicas Reunidas SA: * WINS CONTRACT FOR PROJECT MANAGEMENT SERVICES FOR…
(Adds details on agreement, background from paragraph 2) ANTALYA, Turkey, Nov 12 (Reuters) - C…
Ahmedabad (Gujarat) [India], November 12: Rajesh Power Services Limited (RAJESH) BSE: 544291, ISIN: INE0VN801010, one…